Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Asthenia
ADR ID BADD_A00362
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.001      Asthenia
Description Clinical sign or symptom manifested as debility, or lack or loss of strength and energy. [MeSH]
MedDRA Code 10003549
MeSH ID D001247; D009440; D000073496
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adynamia | Asthenia | Collapse of legs | Debility | Debility marked | Debility, unspecified | Feeling of total lack of energy | Feelings of weakness | General debility | Loss of energy | Nervous debility | Neurasthaenia | Neurasthenia | Strength loss of | Weakness | Weakness generalised | Weakness generalized | Weakness postural | Energy decreased | Frailty | Weakness worsened | Hyposthenia | Cerebro-asthenic syndrome
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02322Ustekinumab--
BADD_D02324Valacyclovir hydrochloride--
BADD_D02325Valdecoxib--
BADD_D02326Valganciclovir--
BADD_D02327Valganciclovir hydrochloride--
BADD_D02328Valproate sodium--
BADD_D02329Valproic acid--
BADD_D02330Valrubicin0.000246%
BADD_D02331Valsartan--
BADD_D02332Vancomycin--
BADD_D02334Vandetanib0.000716%
BADD_D02335Vardenafil--
BADD_D02337Varenicline--
BADD_D02338Varenicline tartrate--
BADD_D02343Velaglucerase alfa--
BADD_D02344Vemurafenib0.004846%
BADD_D02345Venetoclax--
BADD_D02346Venlafaxine--
BADD_D02347Venlafaxine hydrochloride--
BADD_D02348Verapamil0.000969%
BADD_D02351Vernakalant hydrochloride--
BADD_D02352Verteporfin--
BADD_D02353Vesicare--
BADD_D02355Vigabatrin--
BADD_D02356Vilazodone hydrochloride--
BADD_D02357Vildagliptin--
BADD_D02358Vinblastine--
BADD_D02359Vinblastine sulfate--
BADD_D02360Vincristine--
BADD_D02361Vincristine sulfate--
The 43th Page    First    Pre   43 44 45 46 47    Next   Last    Total 47 Pages
ADReCS-Target
ADR Term Drug Name Target